SEC FORM 4
$474,774.45
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sale of 42,666 shares at $11.1277 per share.
Reporting Person Thompson Rahsaan · Officer Title Chief Legal & Compliance · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001434647-26-000073 · filed 2026-08-17 · View filing →